Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx zdravotnictví

ze dne 20. xxxxxxxxx 2014

x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2015

Xxxxxxxxxxxx zdravotnictví xxxxx §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Sb., x ochraně xxxxxxxxx xxxxxx x x xxxxx některých souvisejících xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2015:

1. Antiqenní složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování

1a) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx anatoxinum xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B xxxxxxxxxxxxxx

Xxxxx poliomyelitidis inactivatum xxxxx 1

Xxxxx poliomyelitidis xxxxxxxxxxx typus 2

Virus xxxxxxxxxxxxxxx xxxxxxxxxxx typus 3

Xxxxxxxxxx Xxx: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx influenzae x, Xxxxxx xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x ( DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx

Xxxxxxxx Bordetelly xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx xxxxxxxxxxxx

Xxxxx Poliomyelitidis (xxxxxxxxxxxx)

xxxxx 1 (Xxxxxxx)

xxxxx 2 (MEF-1)

typus 3 (Xxxxxxx)

Xxxxxxxxx tegiminis hepatitidy X

Xxxxxxxxxxx xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx xxx xxxxxx xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (PT) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx b (DTaPHib):

Diphtheriae xxxxxxxxxx ........................................... xxx. 30 mezinárodních jednotek

Tetani xxxxxxxxxx .................................................... min. 40 mezinárodních jednotek

Pertussis xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (FHA) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 mikrogramů

Haemophilus xxxxxxxxxx X ....................................... 10 xxxxxxxxxx

xxx xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x:

1 dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (přibližně 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X do 15 xxx věku:

Antigenum xxxxxxxxx hepatitidis B .......................... 10 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 16 xxx x xxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X ........................... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti spalničkám, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Schwarz) xxx. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx virus attenuatum (XXX 4385) min. 10^3,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) min. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

1xx) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx formě:

Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Mahoney) ........... 40 antigenních X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx X xxxxxxxx*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1x) xxxxxxxx xxxxx proti xxxxxxx xxxxxxxxx Streptococcus xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx pneumoniae xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10A, 11 X, 12F, 14, 15X, 17X, 18C, 19X, 19X, 20, 22X, 23X, 33F ...... 25 mikrogramů x xxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx konjugovaná xxxxx pneumokokovým xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 4

Pneumococcale xxxxxxxxxxxxxxx sérotypus 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 18C

Pneumococcale xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx xxxxxxxxxx ............................... xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ........................................ xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx haemagglutinum filamentosum ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 X jednotek xxxxxxxx

xxxxx 2 (kmen XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx) ................................ 32 X xxxxxxxx antigenu

NEBO

1kb) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):

Xxxxxxxxxx toxoid ....................................... xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Lf)

Tetanický toxoid ....................................... xxxx nebo xxxxx 20 mezinárodních xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx hemaglutinin ................. 5 xxxxxxxxxx

Xxxxxxx xxxx 2+3 ................................ 5 mikrogramů

Pertaktin ............................................. 3 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) ... 40 antigenních X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (inaktivovaný) ... 8 antigenních X xxxxxxxx

Xxxxx poliomyelitis xxxx 3 (inaktivovaný) ... 32 xxxxxxxxxxx X xxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (XXX) xxxxxxx Danisuc 1331 ... 0,75 mg ≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xxx osoby xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X biosyntheticum 20 xxxxxxxxxx; adjuvans XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 xxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx dospělé:

Antigenum xxxxxxxxx xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx

Xxxxx rabiei xxxxxxxxxxx (xxxx Xxxxxx xxxxxx XX/XX 38&xxxx;1503-3X xxxx nebo rovno 2,5 mezinárodních jednotek x 1 dávce (0,5 xx)

2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X virus inactivatum

3. Xxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx

3x) očkovací látka xxxxx xxxxxx hepatitidě X xx formuli xxx xxxxxxx:

Xxxxxxxxx X xxxxx inactivatum

3b) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx pro děti:

Virus xxxxxxxxx X xxxxxxxxxxx

X xxxx 2015 x xxxxxxx xx plánovanou xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx xxxxxxx, xxxxx xxxxxxxx případnou xxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro pravidelná xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx těchto xxxxxxxxxx látek ve Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Xxxxxxx, XXX, x. r.

Informace

Právní xxxxxxx x. 278/2014 Xx. nabyl xxxxxxxxx xxxx 13.12.2014.

Ke xxx uzávěrky xxxxxx xxxxxxx xxxxx xxxxx xx xxxxxxxxx.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.